Ignite Creation Date:
2024-05-05 @ 5:12 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00402467
Status:
COMPLETED
Last Update Posted:
2014-12-23
First Post:
2006-11-21
Brief Title:
An Oral Direct Factor Xa Inhibitor BAY59-7939 for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement a Dose-Ranging Study
Sponsor:
Bayer
Organization:
Bayer
Organization Data
Organization:
Bayer
Class:
INDUSTRY
Study ID:
10945
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bayer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Therapeutic Area Head
Old Organization:
Bayer Healthcare Pharmaceutical Inc